CDC official who oversaw COVID-19 vaccine recommendations has resigned following HHS rollback
An official who oversaw the recommendations for COVID-19 vaccinations at the Atlanta-based Centers for Disease Control has resigned.
Dr. Lakshmi Panagiotakopoulos resigned on Friday.
'My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role,' she wrote in her resignation letter obtained by Channel 2 Action News.
Panagiotakopoulos co-led a part of the CDC's independent panel of vaccine advisers to review evidence for recommendations on COVID vaccines.
Last Week, U.S. Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines will no longer be recommended for healthy children and pregnant women.
In mid-April, advisers had discussed the possibility of narrowing the recommendations for who should receive an annual COVID vaccine -- prioritizing those at higher risk, such as adults over 65 or those with an underlying condition, ABC News reported on Wednesday.
Last Thursday, the CDC updated its website. The agency said that shots may be given to children ages 6 months to 17 years who do not have moderate or severe problems with their immune systems.
Instead of recommending the shots, the CDC now says parents may decide to get their children vaccinated in consultation with a doctor.
TRENDING STORIES:
Driver hospitalized after car flips, split in half during crash on GA highway
Man tries to carjack 2 victims, police say. Then a good Samaritan jumped in to help
Trump threatens to cut Musk's government contracts as their public feud escalates
'The old COVID-19 vaccine recommendations for healthy children under 18 and for pregnant women have been removed from the CDC vaccine schedule,' an HHS spokesperson said in a statement. 'The CDC and HHS encourage individuals to talk with their healthcare provider about any personal medical decision.'
Childhood vaccination rates for COVID-19 are already low — just 13% of children and 23% of adults have received the 2024-25 COVID-19 vaccine, according to CDC data.
Talk of changing the recommendations has been brewing. As the COVID-19 pandemic has waned, experts have discussed the possibility of focusing vaccination efforts on people 65 and older — who are among those most as risk for death and hospitalization.
A CDC advisory panel is set to meet in this month to make recommendations about the fall shots. Among its options are suggesting shots for high-risk groups but still giving lower-risk people the choice to get vaccinated. A committee work group has endorsed the idea.
But Kennedy, a leading anti-vaccine advocate before becoming health secretary, decided not to wait for the scientific panel's review.
The new vaccine recommendation changes, their timing and the way there were announced have created confusion that can be 'incredibly harmful to the success of vaccination programs,' Schwartz said.
'It would be understandable if the public is completely baffled in terms of what the federal government thinks and what the science suggests ... about the evidence for the safety and value of these vaccines,' he added.
American Academy of Pediatrics President Dr. Susan Kressly said the organization is relieved that families wanting COVID-19 shots for their children will still be able to get them.
'However,' she added, 'the deeply flawed process to reach the recommendation raises serious concerns about the stability of the nation's immunization infrastructure and commitment by federal leaders to make sure families can access critical immunizations.'
The Associated Press and ABC News contributed to this article.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration
Hamilton Spectator
4 hours ago
- Hamilton Spectator
Who makes decisions for public health is changing in Hamilton
Community members are now at Hamilton's public health decision-making table after long-awaited governance reform got the green light from the province. 'I think it's so vitally important to have those voices there,' Coun. Cameron Kroetsch said in an interview with The Spectator. 'I think, also, it just frankly gives the community more confidence that we have both councillors and health experts who can give a balanced perspective.' Public health policy will no longer be decided by the 16 members of Hamilton's city council after legislative changes passed third reading on June 3 and received royal assent on June 5 as part of Bill 11 , More Convenient Care Act. Instead, six appointed community members , with health expertise or lived experience, will work alongside six city councillors and one education representative to oversee public health. Coun. Cameron Kroetsch says it is 'vitally important' to have community voices on the board of health. The Progressive Conservative government made the required amendments to the City of Hamilton Act at council's request. 'The community pushed really hard for this,' Kroetsch said. 'It's been a long journey.' City council will provide one final approval at its meeting on June 18 but the vote is considered a formality. The new board is expected to meet for the first time on July 7 — over four years after calls for change started in March 2021 when COVID-19 brought inequities, related to social determinants of health, to the forefront as some groups fared better than others during the pandemic. Advocates — including doctors, social workers and academics — argued for a board of health that better reflects Hamilton's diversity, including racialized residents and those with disabilities. 'We didn't have that kind of community voice available to respond to issues of public health in our city and so I think this is going to be great,' Kroetsch said. 'Having these key people around the table, we learned during COVID, would have made things so much better … I just can't say enough about how important I think it is for community voices to be at the table.' The changes bring Hamilton more in line with about two-thirds of the province's public health units that are overseen by autonomous boards. Hamilton's board will be semi-autonomous as decisions related to the budget, the annual service plan and the appointment of medical officers of health will still be approved by city council. Toronto and Ottawa also have semi autonomous boards. However, policy decisions would no longer need any further approval so the board's vote would be binding. 'There's not really a way for council to override the board of health,' Kroetsch said. 'We've given over that autonomy.' The governance reform initially had the unanimous support of council in January 2024. While awaiting the legislative changes, a public health subcommittee was created that will now become the board of health. Up until now, its decisions needed to be approved by city councillors. But opposition to the changes flared up in May after a disagreement over how restrictive the city should be about drinking on municipal property revealed a divide between councillors and the subcommittee. The proposed changes to the municipal alcohol policy were passed with almost no discussion by the subcommittee. In stark contrast, councillors voted 13-1 against it after a charged debate and an in-camera session to get legal advice. It raised questions about what would happen in the future when the semi-autonomous board of health no longer needed councillors' approval for such policy decisions. The subsequent vote went from unanimous to passing 9-5 on the makeup of the future board of health. But Kroetsch, who has been chairing the subcommittee, expects the transition will now be smooth. 'It's just going to be a new day for Hamilton in terms of having that expert advice from the community on the board of health to be able to weigh in on matters that are important,' Kroetsch said. 'We're talking about something that has literally a life and death impact for people. Public health is one of those areas of municipal governance that can impact people's day to day lives.' Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Hamilton Spectator
4 hours ago
- Hamilton Spectator
Top Hamilton headlines this week: 40 hours in St. Joe's emergency department + ‘Rats and cockroaches own that place now'
The weekend is here, but plenty happened in the Hamilton area this week. Don't miss these top stories from Spectator reporters. Take in a Forge FC game, a car show in Burlington or a street party on Concession, and there are plenty more things to do this weekend. Here are some ideas . Saturday is sun day. Environment Canada is forecasting a high of 25 C. Temperatures are expected to peak at 18 C on a cloudy Sunday and there is a chance of showers. Emergency is a three-part series about St. Joseph's Healthcare emergency department in Hamilton's core. Spec reporter Jon Wells spent 40 hours talking to the patients who come to this eye in the storm of the mental health, homelessness and addiction crisis, and those who work there. Part 2: St. Joe's emergency sees upwards of 200 patients in a 24-hour period Part 3: A surge of homeless patients at the busiest emergency department A Burlington lawyer arrested in connection with a suspected multimillion-dollar Ponzi scheme is under investigation by the Law Society of Ontario for allegedly misusing her trust fund. Robert DeRosa feels forgotten as the world increasingly moves on from COVID-19. Life never went back to normal for the 42-year-old former teacher, who went from running marathons nearly five and half years ago to falling so ill from long COVID that he can't work, lives with his dad and barely leaves his Hamilton Mountain home. Hamilton council will not allow a homeowner to keep the contentious poolside oasis he built on city parkland on the Stoney Creek Mountain. Two days after handing over her May rent, Crystal Wicker said she received a letter from the County of Brant informing her the motel she has called home for over two years was unsafe to live in. Before she had time to process the news, the hydro got cut. Subscribe to our newsletters for the latest local content . Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
